SREBP2 accelerates key neuropathological hallmarks in AD and Huntington disease via cholesterol biosynthesis and transport, and cholesterol-mediated ROS accumulation [64, 65]. This evidence concerns the gene SREBF2 and juvenile Huntington disease.